Join a Study at Hygea Clinic
Help Advance Medical Knowledge
At CM Hygea, we believe better care begins with better understanding. That’s why we invite patients and community members to participate in our ongoing clinical studies. These research efforts are designed to improve health outcomes, expand medical knowledge, and help shape the future of healthcare.
By taking part, you contribute to the development of tomorrow’s care standards and support meaningful medical research. All studies are led by experienced healthcare professionals and conducted with care, confidentiality, and respect.
Participant Interest & Intake Form
Current Studies at Hygea
1. Clinical Trial for Moderate-to-Severe Sjögren’s Disease
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren’s Syndrome
The main purpose of the proposed study is to evaluate the efficacy of efgartigimod PH20 SC in patients with moderate-to-severe Primary Sjögren’s Disease (pSjD). The study consists of a double-blinded placebo-controlled treatment period and an open-label treatment period.
Languages available: English, French
Time commitment: The maximum study duration for participants in both study parts is approximately 105 weeks.
To learn more about the study and find out if you may be eligible, please visit:
2. Preventing Heart Failure Study
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin (Prevent-HF)
The main purpose of the Prevent-HF Phase III randomized, placebo-controlled study is to evaluate the effect of baxdrostat in combination with dapagliflozin, compared to dapagliflozin alone, on the risk of incident heart failure (HF) and cardiovascular (CV) death in adults with type 2 diabetes mellitus (T2DM), hypertension, and other risk factors for heart failure.
Languages available: English, French
Time Commitment: Approximately 34 weeks of active participation, followed by follow-up visits every 4 months until the end of the study.
To learn more about the study and find out if you may be eligible, please visit:
https://clinicaltrials.gov/study/NCT06677060?rank=1